The Role of Adenosine 3′,5′-Monophosphate in the Regulation of Receptors for Thyrotropin and Insulin-Like Growth Factor I in the FRTL5 Rat Thyroid Follicular Cell*
- 1 January 1988
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 122 (1) , 133-136
- https://doi.org/10.1210/endo-122-1-133
Abstract
Although regulatory effects on their own receptors are among the major responses to peptide hormones and growth factors, little is known of the mechanism of these effects. For example, a wealth of evidence indicates that cAMP is the mediator of many, if not most, of the actions of TSH on the growth and function of the thyroid cell, but evidently no information has been available concerning the possibility that cAMP may also mediate the effect of TSH to down-regulate its own receptors. Therefore, we examined this question using FRTL5 cells as a model, since we had previously shown that withdrawal of TSH from their culture medium and its subsequent readdition lead to increases and decreases, respectively, in the number of their TSH receptors. Because the growth of FRTL5 cells in response to TSH is modified by insulin-like growth factor I (IGF-I), we also examined the independent effect of TSH on receptors for IGF-I, the effects of IGF-I alone on both its own receptors and those for TSH, the effects of the two agents when added together, and the role of cAMP in the independent and conjoint effects of TSH and IGF-I on their own and each other''s receptors. Growth of FRTL5 cells in the presence of bovine TSH (bTSH) resulted in a dose-dependent down-regulation of receptors for both bTSH and IGF-I. In contrast, IGF-I alone produced only a modest down-regulation of its own receptors and had no effect on the binding of bTSH. IGF-I did, however, enhance the effect of bTSH on the binding of both ligands. All of the foregoing down-regulatory effects of bTSH, acting both alone and together with IGF-I, were closely mimicked when either (Bu)2cAMP or forskolin was substituted for bTSH. Therefore, cAMP appears to mediate, at least in part, the effects of both bTSH alone and bTSH acting in concert with IGF-I to down-regulate receptors for both mitogens.This publication has 10 references indexed in Scilit:
- Adenosine 3′,5′-Monophosphate Mediates Both the Mitogenic Effect of Thyrotropin and Its Ability to Amplify the Response to Insulin-Like Growth Factor I in FRTL5 Cells*Endocrinology, 1988
- Hormonal Control of Epidermal Growth Factor Receptors by Gonadotropins during Granulosa Cell DifferentiationEndocrinology, 1987
- Characterization and Regulations of the Receptor for Insulin-Like Growth Factor-I in the FRTL-5 Rat Thyroid Follicular Cell Line*Endocrinology, 1987
- INSULIN-LIKE GROWTH FACTOR-I STIMULATES THE GROWTH OF RAT THYROID CELLS IN CULTURE AND SYNERGIZES THE STIMULATION OF DNA SYNTHESIS INDUCED BY TSH AND GRAVES′-IgGEndocrinology, 1986
- Properties and Regulation of the Thyrotropin Receptor in the FRTL5 Rat Thyroid Cell Line*Endocrinology, 1986
- Follicle-stimulating hormone enhances somatomedin C binding to cultured rat granulosa cells. Evidence for cAMP dependence.Journal of Biological Chemistry, 1986
- Insulin-Like Growth Factor Receptors in Rat Placental Membranes*Endocrinology, 1984
- Cyclic Nucleotides Can Induce Luteinizing Hormone Receptor in Cultured Granulosa Cells*Endocrinology, 1983
- Characterization of the Somatomedin-C/Insulin-Like Growth Factor I (SM-C/IGF-I) Receptor on Cultured Human Fibroblast Monolayers: Regulation of Receptor Concentrations by SM-C/IGF-I and Insulin*Journal of Clinical Endocrinology & Metabolism, 1982
- Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle.Proceedings of the National Academy of Sciences, 1980